Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein (Q42041695)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 2005

Language	Label	Description	Also known as
English	Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein	scientific article published on April 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

5

object named as

Bernard Moss

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

Anjeanette Roberts

2

object named as

Anjeanette Roberts

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

author name string

Himani Bisht

1

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

Leatrice Vogel

3

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

language of work or name

0 references

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

334

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

160-165

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS.

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

The Genome sequence of the SARS-associated coronavirus

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Virology: SARS virus infection of cats and ferrets

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

The SARS-CoV S glycoprotein: expression and functional characterization

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2005.01.042

7 January 2021

Identifiers

10.1016/J.VIROL.2005.01.042

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42041695&oldid=1932459060"